Hemoglobinopathies Treatment Market Size, Share, Growth Analysis, By Treatment(Stem cell therapy, blood transfusion, iron chelation therapy and others), By Application(Thalassemia, sick cell anaemia and others), By Region - Industry Forecast 2024-2031

Hemoglobinopathies Treatment Market size was valued at USD 8.32 billion in 2022 and is poised to grow from USD 9.07 billion in 2023 to USD 18.07 billion by 2031, at a CAGR of 9% during the forecast period (2024-2031).

血红蛋白病治疗市场规模于2022年达到83.2亿美元，预计将从2023年的90.7亿美元增长至2031年的180.7亿美元，在预测期内（2024-2031年）的复合年增长率将达到9%。